Integrated Wealth Concepts’s NeuroOne Medical Technologies NMTC Stock Holding History

Integrated Wealth Concepts’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24	Buy	+8	New	+$33	﹤0.01%	5871

Other funds holding NMTC

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Integrated Wealth Concepts's NMTC Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in NeuroOne Medical Technologies (NMTC) in Q2 2026: 8 shares worth $24. The stake represents ﹤0.01% of the portfolio and ranks #5871 among its holdings.

27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

Integrated Wealth Concepts held 8 shares of NeuroOne Medical Technologies worth $24 as of Q2 2026.
NeuroOne Medical Technologies was a new Integrated Wealth Concepts position in Q2 2026.
NeuroOne Medical Technologies made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5871 holding.
27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.